Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012
More Than 100 Studies on PillCam(R) Capsule Endoscopy and Given Imaging Reflux and Manometry Products Presented
(firmenpresse) - YOQNEAM, ISRAEL -- (Marketwire) -- 05/18/12 -- Given Imaging (NASDAQ: GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that a wide range of new studies will be presented at Digestive Disease Week® (DDW)® that confirm the value of its PillCam® SB, reflux and manometry products including Bravo, Digitrapper and Manoscan, and PillCam® COLON 2 in detecting and monitoring gastrointestinal diseases. Studies on the topics of pediatric Crohn's disease, upper gastrointestinal care, and new uses of PillCam SB will be presented, as well as studies on PillCam COLON 2. Given Imaging will be exhibiting at booth #2015 during DDW, taking place in San Diego from May 19-22, 2012.
"Given Imaging is proud of its role as a leader in developing innovative products for GI diagnostics," said Homi Shamir, president and CEO, Given Imaging. "Since 2001, when Given Imaging introduced capsule endoscopy to gastroenterologists, more than one and a half million PillCam capsules have been ingested by patients to help doctors improve the detection and monitoring of GI diseases. We thank the physicians and nurses who continue to advance clinical knowledge about diseases of the GI tract and to improve patient care."
Key studies to be presented at the meeting include:
(Embargoed until May 19, 2012, 8 am PT)
(Sa1995)
Poster Presentation/Investigators: Steve B. Min, Minou Le-Carlson, Jennifer Gebbia, Kelly Haas, Shervin Rabizadeh, Neel K. Mann, Simon K. Lo, Gil Y. Melmed, Marla Dubinsky
Time: 8 am to 5 pm
(Embargoed until May 19, 2012, 8 am PT)
(Sa1992)
Poster Presentation/Investigators: Stanley A. Cohen, Angela N. Stallworth, Bailey M. Koch, David H. Mason, Jeffrey Blumenthal, Benjamin D. Gold
Time: 8 am to 5 pm
(Embargoed until May 19, 2012, 11:30 am PT)
(153)
Topic Forum/Investigators: Neel K. Mann, Navin Paul, Simon K. Lo
Time: 11:30 am
(Embargoed until May 19, 2012, 2:30 PT)
(216)
Research Forum/Investigators: Dhavan A. Parikh, Mohit Mittal, Surinder K. Mann, Preethika S. Ekanayake
Time: 2:30 pm
(Embargoed until May 19, 2012, 8 am PT)
(Sa1742)
Poster Presentation/Investigators: Victoria Gomez, Mihir K. Patel, Mark E. Stark, Frank Lukens
Time: 8 am to 5 pm
(Embargoed until May 19, 2012, 8 am PT)
(Sa1592)
Poster Presentation/Investigators: Yasushi Sato, Masahiro Hirakawa, Hiroyuki Ohnuma, Kohichi Takada, Tsutomu Sato, Koji Miyanishi, Rishu Takimoto, Masayoshi Kobune, Junji Kato
Time: 8 am to 5 pm
(Embargoed until May 19, 2012, 3:15 pm PT)
: (219)
Research forum/Investigators: Samuel N. Adler, Yishai Sompolinsky, Yoav C. Metzger, Cesare Hassan
Time: 3:15 pm
(Embargoed until May 21, 2012, 8 am PT)
(Mo1390)
Poster Presentation/Investigators: Mileidis E. San Juan-Acosta, Alba Belda-Cuesta, Angel Caunedo-Alvarez, Javier Romero-Vazquez, Blas J. Gomez-Rodriguez, Maria L. Morales, Federico Arguelles-Arias, Juan M Herrerias
Time: 8 am to 5 pm
(Embargoed until May 19, 8 am PT)
(Sa1352)
Poster Presentation/Investigators: Yinglian Xiao, Joan Chen, Annemijn de Ruigh, Frédéric Nicodème, Mary Kwasny, Chang Lu, Lubomyr Boris, Gabriela I. Escobar, Peter J. Kahrilas, John E. Pandolfino
Time: 8 am to 5 pm
(Embargoed until May 22, 2012, 8 am PT)
(Tu1415)
Poster Presentation/Investigators: Enrique Coss-Adame, Jessica Valestin, Satish S. Rao
Time: 8 am to 5 pm
(Embargoed until May 19, 8 am PT)
(Sa1196)
Poster Presentation/Investigators: Abhinav Sankineni, Lucy Salieb, Martha J. Harrison, Robert S. Fisher, Henry P. Parkman
Time: 8 am to 5 pm
(Embargoed until May 19, 8 am PT)
(Sa1199)
Poster Presentation/Investigators: Junichi Akiyama, Pankaj J. Pasricha, Linda Anh B. Nguyen
Time: 8 am to 5 pm
(Embargoed until May 19, 10:30 am PT)
(1137a)
Topic Forum/Investigators: Mark R. Fox, John E. Pandolfino, Jafar Jafari, Dieter Menne, Ana T. Abreu, Auke Bogte, Alessandra Elvevi, Antonio Ruiz de Leon, Boudewijn F. Kessing, Lubomyr Boris, Jose M. Remes Troche, C. Prakash Gyawali, Candice L. Wilshire, Dorata Wasko-Czopnik, Francois Mion, Heiko Fruehauf, Frank Zerbib, Oliver Gellersen, Henriette Heinrich, Julio Perez de la Serna, Matthias M. Sauter, Gerrit J. Hemmink, Marcin Banasiuk, Miguel A. Valdovinos, Uscinowicz Miroslawa, Monika A. Kwiatek, Jeff Wright, Pim W. Weijenborg, Rami Sweis, Sabine Roman, Rukiye Vardar, Sudip K. Ghosh, Radu Tutuian, Wout O. Rohof, Albert J. Bredenoord
Time: 10:30 am
(Embargoed until May 19, 2012, 8 am PT)
(Sa1726)
Poster Presentation/Investigators: Sujievvan Chandran, Paul Urquhart, Adam Testro, Sim Ong, Edward Shelton, Richard La Nauze, Rhys Vaughan, William Kemp, Gregor J. Brown, Paul R. Froomes
Time: 8 am to 5 pm
(Embargoed until May 20, 8 am PT)
(Su1100)
Poster Presentation/Investigators: Gabriela I. Escobar, Meghan Thompson, Meghan Barrett, Chang Lu, Lubomyr Boris, Peter J. Kahrilas, John E. Pandolfino
Time: 8 am to 5 pm
DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy and the Society for Surgery of the Alimentary Tract, DDW takes place May 19 - 22, 2012, at the San Diego Convention Center. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. For more information, visit .
Since pioneering the field of capsule endoscopy in 2001, Given Imaging has become a world leader in GI medical devices, offering health care providers a range of innovative options for visualizing, diagnosing and monitoring the digestive system. The company offers a broad product portfolio including PillCam® video capsules for the small bowel, esophagus and colon, industry-leading ManoScan™ high resolution manometry and Bravo® pH and Digitrapper® pH and impedance products. Given Imaging is committed to delivering breakthrough innovations to the GI community and supporting its ongoing clinical needs. Given Imaging's headquarters are located in Yoqneam, Israel, with operating subsidiaries in the United States, Germany, France, Japan, Australia, Vietnam and Hong Kong. For more information, please visit .
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, projections about our business and our future revenues, expenses and profitability. Forward-looking statements may be, but are not necessarily, identified by the use of forward-looking terminology such as "may," "anticipates," "estimates," "expects," "intends," "plans," "believes," and words and terms of similar substance. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual events, results, performance, circumstances or achievements of the Company to be materially different from any future events, results, performance, circumstances or achievements expressed or implied by such forward-looking statements. Factors that could cause actual events, results, performance, circumstances or achievements to differ from such forward-looking statements include, but are not limited to, the following: (1) our ability to develop and bring to market new products, (2) our ability to successfully complete any necessary or required clinical studies with our products, (3) our ability to receive regulatory clearance or approval to market our products or changes in regulatory environment, (4) our success in implementing our sales, marketing and manufacturing plans, (5) the level of adoption of our products by medical practitioners, (6) the emergence of other products that may make our products obsolete, (7) lack of an appropriate bowel preparation materials to be used with our PillCam COLON capsule, (8) protection and validity of patents and other intellectual property rights, (9) the impact of currency exchange rates, (10) the effect of competition by other companies, (11) the outcome of significant litigation, (12) our ability to obtain reimbursement for our product from government and commercial payors, (13) quarterly variations in operating results, (14) the possibility of armed conflict or civil or military unrest in Israel, (15) the impact of global economic conditions, (16) our ability to successfully integrate acquired businesses, (17) changes and reforms in applicable healthcare laws and regulations, (18) quality issues and adverse events related to our products, such as capsule retention, aspiration and failure to attach or detach, bleeding or perforation that could require us to recall products and impact our sales and net income, and (19) other risks and factors disclosed in our filings with the U.S. Securities and Exchange Commission, including, but not limited to, risks and factors identified under such headings as "Risk Factors," "Cautionary Language Regarding Forward-Looking Statements" and "Operating Results and Financial Review and Prospects" in the Company's Annual Report on Form 20-F for the year ended December 31, 2011. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Except for the Company's ongoing obligations to disclose material information under the applicable securities laws, it undertakes no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.
:
Fern Lazar/David Carey
Lazar Partners Ltd.
212-867-1768
Nava Ladin
Gelbart Kahana Investor Relations
+972-3-6074717
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.05.2012 - 14:01 Uhr
Sprache: Deutsch
News-ID 1116119
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
YOQNEAM, ISRAEL
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 415 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
Given Imaging (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
